#CryptoCorner #Podcast Episode 514: #Stocks discussed: (NasdaqGS: $MARA) (NasdaqCM: $EQOS)

 

 

 

#CryptoCorner #Podcast Episode 514: #Stocks discussed: (NasdaqGS: $MARA) (NasdaqCM: $EQOS)

 

#Bitcoin Reclaims $34K After Weekend Slump, Marathon Buys $150 Million in BTC, Diginex Enters Partnership with GSR Markets, and Grayscale Donating $1 Million to #Crypto Advocate Coin Center

 

Point Roberts, WA, Delta BC January 25, 2021 -  Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving cryptocurrency stocks and the crypto market.

 

Listen to today’s Crypto Corner Podcast:  

https://www.investorideas.com/Audio/Podcasts/2021/012521-CryptoMarket.mp3

 

Read this in full at https://www.investorideas.com/news/2021/crypto-corner/01251MARA-EQOS.asp

 

Get the Crypto Corner Podcast on iTunes

 

Get the Crypto corner on Spotify

 

Stocks discussed: (NasdaqGS:MARA) (NasdaqCM:EQOS)

 

As we begin a new week, Bitcoin (BTC) is back in the green, having emerged from a slump that it entered last Thursday, according to data from CoinMarketCap. At press time, it is trading for about $34,350, up more than six percent in the last 24 hours. This is still well below Bitcoin’s all-time high trading price of around $42,000, reached on January 8, 2021. But Bitcoin is not alone in reaching an ATH this month, as Ether (ETH) has surpassed its trading price record (currently $1,467 in the last 24 hours) and has yet to see a Bitcoin-style downtick.

 

Marathon Patent Group, Inc. (NasdaqGS:MARA) has purchased 4,812.66 BTC, worth $150 million. The purchase was conducted with Bitcoin-focussed technology and financial services firm NYDIG. Merrick Okamoto, Marathon’s chairman & CEO, said:

 

“To date, we have contracted to purchase 103,060 miners, all of which are currently expected to be delivered and fully deployed by the end of the first quarter of fiscal 2022. If all miners were operational today, based on the Bitcoin network’s current difficulty rate, we would produce approximately 55-60 bitcoins per day. However, by leveraging our cash on hand to invest in Bitcoin now, we have transformed our potential to be a pure-play investment into a reality. I would like to thank the entire NYDIG team for offering their unique products and services for public companies, and for working with us to expedite this process and ensure the transaction was made on the best possible terms for our business and our shareholders.”

 

Digital assets financial services company Diginex Limited (NasdaqCM:EQOS) has entered into a strategic partnership with GSR Markets, the latter of which is described as “a leading global market maker for cryptocurrency spot and crypto derivative markets.” According to the press release, GSR will provide liquidity “in all markets from the recently launched BTC perpetual futures product,” on Diginex’s EQUOS crypto exchange, and will “play a critical role in supporting the rollout of Diginex's future product roadmap, which include dated futures and options.” Richard Byworth, CEO of Diginex, explained:

 

"As an exchange that avoids the conflict of interest of making markets against its own participants, the partnership with GSR is key to growing the depth and liquidity in all our trading pairs. GSR are one of the largest market makers in crypto and crypto derivatives, so longer term the partnership will evolve more broadly into liquidity provision around key offerings like options, structured products and borrowing and lending."

 

Grayscale Investments has announced that it will be donating $1 million to cryptocurrency non-profit research and advocacy center Coin Center, and pledged to match donations to Coin Center of up to an additional $1 million through next month. Michael Sonnenshein, CEO of Grayscale Investments, said:

 

“There’s not been a better time to invest in the growth of this industry, following a year which saw cryptocurrencies becoming recognized as a bona fide asset class, enjoying the participation of the broader investment community and notable financial services institutions.”

 

Sam Mowers, Investorideas

 

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

 

 

Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories 

#CBD #Stock Link Reservations Inc/LinkResPet (OTC: $LRSV) Expands CBD products from #pets to people; @res_pet

#CBD #Stock Link Reservations Inc/LinkResPet (OTC: $LRSV) Expands CBD products from #pets to people; @res_pet    

 

London, UK, January 25, 2021– Investorideas.com Newswire Breaking CBD stock news -Link Reservations Inc. (OTC: LRSV), a provider of cannabidiol (CBD) products specifically tailored for pets, announces it has purchased DailyLifeCBD – a website selling CBD products for people. As part of this, the Company has acquired both the DailyLifeCBD IP, website domain and existing product line. By LRSV expanding into selling CBD products for people its positioned for substantial potential revenue growth. Our focus is to continue focusing on acquistions , expanding products, growing revenue & increasing shareholder value

 

Read this news, featuring LRSV in full at https://www.investorideas.com/news/2021/cannabis/01251LRSV-CBD-Pets-People.asp

LRSV targeted DailyLifeCBD in a bid to expand its presence in the CBD market and purchased the website & existing product line. The purchase means Link Reservations can expand its operations with a sister site to LinkResPet, which will be focused on products for the human market.

 

“This is an exciting opportunity for LRSV as we move to expand into the highly popular and lucrative CBD wellness sector”, commented Rene Lauritsen, CEO at LinkResPet. “By having a base for CBD wellness products, we will be able to grow our target audience organically to start with, by offering our existing pet owner customers products for both their pets and soon themselves, through a whole new range tailored for personal use. At the same time, the possibility to grow our market presence and customer base beyond that is very significant, as people don’t need to have a pet to be interested in our CBD products”, he explained.

 

According to a Nielsen study, approximately 74% of consumers who purchase CBD products own pets, and 24% of pet owners use hemp or CBD for themselves, their pet or both. In fact, about 26% of dog owners are using CBD products, of which half are already administering it to their dogs.

 

The Company plans to initiate activities through DailyLifeCBD with a range of non-edible lifestyle products and expand on the range as the site and demand grows.

 

For more information about DailyLifeCBD please visit: https://dailylifecbd.com/

 

For more information about LinkResPet, please visit www.linkrespet.com or follow them on Twitter on @ HYPERLINK "https://twitter.com/res_pet"res_pet

 

About Link Reservations Inc.

Link Reservations Inc is CBD Petcare provider dedicated to improving the health and life conditions of pets worldwide. Developing and marketing hemp-based CBD products for cats, dogs and horses, the Company is currently present in Europe and in the US. A pioneer in the area, Link Reservations Inc products can be found under its brand LinkResPets (www.linkrespet.com). 

 

Forward-Looking Statements & Disclaimers:
The information in this Press Release includes certain "forward-looking" statements within the meaning of the Safe Harbor provisions of Federal Securities Laws, as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. Statements in this document, which are not purely historical, are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Investors are cautioned that such statements are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this release, and the Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date of this release except as required by law.

 

Linkreservations Inc

400 Thames Valley Park Drive

Reading Berkshire RG6 1 PT

United Kingdom

Phone: +44 330 808 0897

 

Paid News -Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure : this news release featuring Link Reservations is a paid for service on Investorideas.com  More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

 

Investor Ideas #Podcast Corner - Chairman, CEO of Sigyn Therapeutics, Inc. (OTC: $SIGY) Discusses Treatment of Life-Threatening Conditions Induced by #Cytokine Storm Syndrome; @Sigyn_inc

 

 

 

 

Investor Ideas #Podcast Corner - Chairman, CEO of Sigyn Therapeutics, Inc. (OTC: $SIGY) Discusses Treatment of Life-Threatening Conditions Induced by #Cytokine Storm Syndrome; @Sigyn_inc

 

Point Roberts WA, Delta BC, January 25, 2021 - Investorideas.com, a global news source and leading retail investor and trader resource issues a new CEO interview for the Podcast Corner. In today’s special edition, Investor Ideas talks to Sigyn Therapeutics, Inc. (OTCMarkets: SIGY) Chairman and CEO, Jim Joyce.

 

  

Previously, Mr. Joyce was the founder and former Chairman and CEO of Aethlon Medical, Inc. (NASDAQ: AEMD)

 

Listen to today’s Podcast:  

https://www.investorideas.com/Audio/Podcasts/2021/012021SIGY-CEO-Interview.mp3

 

Read this in full at https://www.investorideas.com/news/2021/biotech/01251Podcast-SIGY-CEO-Interview.asp

 

Listen to Investor Ideas podcasts on Spotify

 

Mr. Joyce discusses Sigyn Therapeutics vision for addressing life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome stating, “Cytokine Storm Syndrome is a dis-regulated immune response that results in the overproduction of inflammatory cytokines that can induce organ failure and cause death. It can be triggered by a wide range of infectious conditions and is a leading cause of death related to severe COVID-19 infections.  It also underlies sepsis, which is the number one cause of in-hospital deaths worldwide and an annual market opportunity that exceeds $20 billion.”  Mr Joyce added that: “Cytokine Storm Syndrome can also be triggered by non-infectious disease conditions such as an adverse response to drug therapies including emerging cancer immunotherapies.”

 

Mr. Joyce further discussed how the limitations of single-target drugs have created an increased interest in extracorporeal blood purification technologies that can address a broad-spectrum of inflammatory targets, whereas anti-Cytokine drug agents are limited to a single Cytokine target.

 

Continued: “We really see two pioneering devices and they happen to be associated with public companies. One is the CytoSorb device from CytoSorbents Corporation (NASDAQ: CTSO) which has a market value of approximately $400 million. This device is designed to reduce the presence of a broad-spectrum of inflammatory cytokines from circulation.”

 

Continued: “The other device is the Toraymyxin Device which is a product of Toray Industries, Inc. (3402.T) based in Japan.  This is one of about several products from Toray that drives a market value of about $10 billion. The Toraymyxin product eliminates circulating endotoxins, which is a potent activator of the cytokine storm.”

 

Continued: “However, it does not address inflammatory Cytokines.  Inversely, CytoSorb addresses inflammatory Cytokines but doesn't address endotoxin. So that's something we took into great consideration when we designed Sigyn Therapy to simultaneously address inflammatory Cytokines, endotoxin and much larger CytoVesicles that transport inflammatory Cytokine cargos throughout the circulatory system (OTCMarkets: SIGY).”

 

Sigyn Therapeutics is a development-stage therapeutic technology company headquartered in San Diego, California, USA. Their focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome. Their mission is to save lives.

 

Sigyn Therapy™ is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

 

Joyce also discusses his previous leadership role at Aethlon Medical, Inc. (NASDAQ: AEMD) where he oversaw the development of the Hemopurifier to treat life-threatening viral infections and address tumor-derived exosomes in cancer patients as a great experience prior to founding Sigyn Therapeutics, Inc.

 

To learn more, visit www.SigynTherapeutics.com  or www.SigynTherapy.com

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash  and others.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Disclosure: the distribution of this podcast was paid for by Sigyn Therapeutics (2000) Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800-665-0411

 

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

 

Breaking #Cleantech #Stock News: dynaCERT (TSX: $DYA.TO) (OTCQX: $DYFSF) (FRA: DMJ) Announces Major #CarbonCredit Advancements with Verra; @dynaCERT

Breaking #Cleantech #Stock News: dynaCERT (TSX: $DYA.TO) (OTCQX: $DYFSF) (FRA: DMJ) Announces Major #CarbonCredit Advancements with Verra; @dynaCERT

 

Toronto, ON, January 25, 2021 (Investorideas.com Newswire) dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that the executive management of Verra, which manages the world's largest greenhouse gas program, the Verified Carbon Standard, has approved the concept note of dynaCERT that is designed to secure Carbon Credits by deploying dynaCERT's patented HydraGEN™ Technology and HydraLytica™ Telematics on a global basis.

 

Read this news, featuring dynaCERT in full at

https://www.investorideas.com/CO/DYA/news/2021/01251Verra.asp

 

Hydrogen Economy Leaders Collaborating with Verra

dynaCERT's forward-thinking management is fully committed to maintaining a Canadian leadership role in the new Hydrogen Economy while collaborating significantly with other top-ranked industry leaders, such as Verra, to further supplement and broaden the benefits of the Company's clean-technology line of products currently available to the global market.

 

United Nations Clean Development Mechanism

This concept note approval by Verra is unique because no such similar methodology is in use globally for mobile transportation vehicles. After discussion and thorough research, Verra approved the concept note designed to create dynaCERT's new Verified Carbon Standard (VCS) Methodology under Verra's VCS Program using the proposed revisions by dynaCERT and the Clean Development Mechanism of the United Nations enacted by the United Nations' "Framework Convention on Climate Change, regarding emission reductions through improved efficiency of vehicle fleets", i.e., AMS-III.B.C.

 

About Verra

Verra is a global leader helping to tackle the world's most intractable environmental and social challenges by developing and managing standards that help the private sector, countries, and civil society achieve ambitious sustainable development and climate action goals. Verra's global standards and frameworks serve as linchpins for channeling finance towards high-impact activities that tackle some of the most pressing environmental issues of our day. Website: www.verra.org

 

The VCS Program of Verra

The VCS Program is the world's most widely used voluntary GHG program. The VCS Program provides a pathway for carbon projects to achieve certification through a third-party audit process. Successful certification can result in the generation of a VCU (Verified Carbon Unit). Since its launch in 2006, the VCS Program has grown into the world's largest voluntary GHG program. Projects certified under the VCS Program include dozens of technologies and measures which result in GHG emission reductions and removals, including forest and wetland conservation and restoration, agricultural land management, transport efficiency improvements, and many others. Over 1,600 certified VCS Program projects have collectively reduced or removed more than 550 million tonnes of carbon and other GHG emissions from the atmosphere, the equivalent of more than 120 million passenger vehicles being taken off the road for one year.

 

Monika Wojcik, founder of Environmental Partners, dynaCERT's expert Carbon Credit consultant based in London, UK, said, "Approval of the Concept Note is an important landmark for clients of dynaCERT expecting to develop carbon reduction projects. Carbon Credits issued from such upcoming projects can reduce the adoption costs of dynaCERT's HydraGEN™ Technology. Public awareness and support of Climate Change has become more visible during the COVID 19 crisis. Now, the emissions reduction by industries ready for HydraGEN™ Technology is more urgent than ever."

 

Jim Payne, CEO of dynaCERT, stated, "Verra's approvals bring to dynaCERT the high profile and the applauded stimulus to further our technological triumphs for the global sale of Carbon Credits. It is a great honour of dynaCERT to work side by side with an accomplished and highly respected international organization such as Verra, and with its expert specialists in GHG's. This great honour is backed by our commitment at dynaCERT to constantly advance our innovations in accordance with the environmental mission of the Paris Accord, the United Nations and international organizations that share our corporate vision.

dynaCERT welcomes Verra. We all look forward to our noteworthy alliance together in the weeks, months and years to come as we continue to grow and expand our technology for today and into the future of the New Hydrogen Economy."

 

Methodology of the United Nations

More information about the methodology of the United Nations for reductions of emissions of vehicles under the AMS-III.B.C. may be found here:

https://cdm.unfccc.int/methodologies/DB/13LQNV5A5EKORXUG3607N7ROBX6J6K

 

About dynaCERT Inc.

dynaCERT Inc. manufactures and distributes Carbon Emission Reduction Technology for use with internal combustion engines. As part of the growing global hydrogen economy, our patented technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency. Our technology is designed for use with many types and sizes of diesel engines used in on-road vehicles, reefer trailers, off-road construction, power generation, mining and forestry equipment, marine vessels and railroad locomotives. Website: www.dynaCERT.com.

 

READER ADVISORY

Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance of achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.

Forward-looking information is based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether our strategies and business plans will yield the expected benefits; availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; the uncertainty of the emerging hydrogen economy; including the hydrogen economy moving at a pace not anticipated; our ability to secure and maintain strategic relationships and distribution agreements; and the other risk factors disclosed under our profile on SEDAR at www.sedar.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.

 

The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

 

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of the release.

 

On Behalf of the Board

Murray James Payne, CEO

 

Contacts

Jim Payne, CEO & President
dynaCERT Inc.
#101 – 501 Alliance Avenue
Toronto, Ontario M6N 2J1
+1 (416) 766-9691 x 2
jpayne@dynaCERT.com

 

Investor Relations
dynaCERT Inc.
Nancy Massicotte
+1 (416) 766-9691 x 1
nmassicotte@dynaCERT.com

 

dynaCERT Inc. (TSX:DYA.TO) (DYFSF) is a featured Renewable Energy / Fuel Cell stock on Investorideas.com

 

Visit profile page

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire

https://www.investorideas.com/News-Upload/ Disclosure: dynaCERT Inc. is a paid featured renewable energy stock on Investorideas.com effective July 8th 2020. Additional info regarding BC Residents: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

 

 

RenewableEnergyStocks.com: investing ideas in renewable energy stocks

Like Renewable Energy Stocks? View our Renewable Energy Stocks Directory

Get News Alerts on Renewable Energy Stocks